transdermal ozone shows no adverse changes to blood count or red blood cell integrity
Ozone therapy produced no significant changes in blood count elements and no evidence of hemolysis or significant changes in bilirubin levels, confirming its safety profile.
What this means for you
Knowing that blood markers — including red blood cell health and bilirubin levels — stayed stable is reassuring for anyone curious about long-term wellness routines. It suggests the body tolerates this level of ozone exposure without disrupting normal blood function, which matters if you're thinking about regular sessions.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.